CClinicalTrials.gg
CompletedNCT05235243Updated Feb 11, 2022

Can Mindfulness and Self-monitoring Improve Control Over Maladaptive Daydreaming?

An interventional study of Online therapeutic intervention for maladaptive daydreaming based on mindfulness and self-monitoring and Online therapeutic intervention for maladaptive daydreaming based on mindfulness in Internet-Based Intervention, Psychological Intervention and Intervention Study, sponsored by University of Haifa. Completed at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-02-11.

Sponsored by University of Haifa · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Dec 2018, registered Jan 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
697
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Maladaptive daydreaming (MD) is a compulsive form of daydreaming that causes distress and functional impairment among tens of thousands of self-diagnosed sufferers. This is the first controlled treatment trial for MD. The investigators built an internet-based self-help program for MD and tested the effectiveness of mindfulness and self-monitoring in improving control over MD, comparing three groups across three measurement points in time.

Read the detailed description

Objective: Maladaptive daydreaming (MD) is a compulsive form of daydreaming that causes distress and functional impairment among tens of thousands of self-diagnosed sufferers. This is the first controlled treatment trial for MD. Method: The investigators built an internet-based self-help program for MD and tested the effectiveness of mindfulness and self-monitoring in improving control over MD, compared to internet-based support as usual (waiting-list group). Participants were randomly assigned to three groups and measured across three points in time (baseline, post-intervention, and 6 months follow-up). The investigators measured the change in daydreaming pathology (MDS-16), daydreaming frequency (DDFS), and daydreaming functioning (DWSAS), alongside changes in psychiatric symptoms (BSI), and intervention outcome (OQ). Changes in mindful attention and awareness skills, compliance with program requirements, and feedback to the program were also measured.

02

Conditions studied

  • Internet-Based Intervention
  • Psychological Intervention
  • Intervention Study

Keywords

  • maladaptive daydreaming
  • immersive daydreaming
  • absorption
  • dissociation
  • behavioral addiction
  • compulsive behavior
  • RCT
03

In context

Lead sponsor

University of Haifa is the lead sponsor of 101 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age above 18 years
  • MD diagnosis
  • Not being in any concurrent treatment for MD
  • English fluent
  • Daily access to the internet, and to a device with internet access
  • Give informed consent to the study
  • Respondents who reported being on a stable dose of medication for at least three months could take part in the study provided that they did not change their dosages while participating in the study.

Exclusion criteria

Exclusion Criteria:

  • Age under 18 years
  • No MD diagnosis
  • In concurrent psychology therapy for MD
  • Not fluent in English
  • Not having a daily internet access
  • Taking medication for less than three months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
697 participants (actual)

Study arms

  • Experimental
    The Full Intervention (FI) group

    The full intervention (FI) group received a psycho-education module about MD and its addictive behavior mechanism, a motivation enhancement module based on motivational interviewing, mindfulness modules, and self-monitoring modules.

    Other: Online therapeutic intervention for maladaptive daydreaming based on mindfulness and self-monitoring

  • Active comparator
    The partial intervention (PI) group

    The partial intervention (PI) group received an intervention identical to the FI group (a psycho-education module about MD and its addictive behavior mechanism, a motivation enhancement module based on motivational interviewing, mindfulness modules) with the exclusion of the self-monitoring modules.

    Other: Online therapeutic intervention for maladaptive daydreaming based on mindfulness

  • No intervention
    Waiting List (WL) group

    Waiting List (WL) group did not undergo any intervention during the study period. However, WL participants were told that the program will commence in three months. During their waiting time participants were instructed to reduce their daydreaming activity to the best of their ability. Since all participants were recruited for this study from an online support forum (that is not part of this research design), the investigators labeled WL as the Internet Support as Usual (ISAU) group.

Interventions

  • OtherOnline therapeutic intervention for maladaptive daydreaming based on mindfulness and self-monitoring

    An 8-weeks internet-based self-guided intervention program, accompanied by e-mail. The content of the intervention and training modules comprised texts, illustrations, explanatory video and audio lectures, as well as interactive worksheets embedded in each week's lesson. Typically, a lesson started with a textual description of its target and duration. Then, participants received a summary of what had been taught thus far, and finally, a novel technique or skill was introduced. Each lesson required about 60 minutes to complete. Users had open access to web pages of previous lessons. Upon completion of each lesson, participants received a list of home assignments to practice during the following week. Our internet-based program featured a notification and download center containing the program's materials and pertinent messages from the researchers.

    Also known as: Maladaptive daydreaming treatment program (MDTP)

  • OtherOnline therapeutic intervention for maladaptive daydreaming based on mindfulness

    An 8-weeks internet-based self-guided intervention program, accompanied by e-mail. The content of the intervention and training modules comprised texts, illustrations, explanatory video and audio lectures, as well as interactive worksheets embedded in each week's lesson. Typically, a lesson started with a textual description of its target and duration. Then, participants received a summary of what had been taught thus far, and finally, a novel technique or skill was introduced. Each lesson required about 60 minutes to complete. Users had open access to web pages of previous lessons. Upon completion of each lesson, participants received a list of home assignments to practice during the following week. Our internet-based program featured a notification and download center containing the program's materials and pertinent messages from the researchers.

    Also known as: Maladaptive daydreaming treatment program lite (MDTP)

06

What researchers measure

Primary outcomes

  1. Change from baseline in maladaptive daydreaming

    Change in the 16-item Maladaptive Daydreaming Scale (MDS-16) compared to baseline, measured 2 months and 6 months post-intervention. The MDS-16 is the primary self-report scale that gauges maladaptive daydreaming on a 10-point Likert scale. Scores range from 0 to 100, with the mean score of 40 set as an evidence-based cut-off score for clinical-level MD. Higher scores indicate an elevated level of maladaptive daydreaming, hence, a worse outcome.

    Time frame: Baseline, post, and follow-up (8 month total)

  2. Change from baseline in daydreaming frequency

    Change in the Daydreaming Frequency Scale (DDFS) compared to baseline, measured 2 months and 6 months post-intervention. The DDFS is a 12-item subscale of the Imaginal Processes Inventory, gauging reported daydreaming frequency. Items are marked on a 5-point Likert scale. Scores range from 12 to 60. Higher scores indicate an elevated frequency of daydreaming, hence, a worse outcome.

    Time frame: Baseline, post, and follow-up (8 month total)

  3. Change from baseline in work and social adjustment

    Change in the Daydreaming Work and Social Adjustment Scale (DWSAS) compared to baseline, measured 2 months and 6 months post-intervention. The DWSAS is a 6-item measure assessing adjustment and disfunction in relation to daydreaming. Items are ranked on a 9-point Likert scale ranging from 0 to 8. The DWSAS scores range from 0 to 48. A score of 12 or lower indicates "no pathology and disfunction". Scores between 12 and 24 indicate "pathology and impaired function", while scores of 24 or above suggest "severe pathology and impaired function".

    Time frame: Baseline, post, and follow-up (8 month total)

Secondary outcomes

  1. Change from baseline in psychiatric symptoms

    Change in the Brief Symptom Inventory (BSI) compared to baseline, measured 2 months and 6 months post-intervention. The BSI is a 53-item scale rated on a 5-point Likert scale of general psychopathology. The BSI is divided into nine subscales: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and four additional items. The BSI total score ranges from 0 to 4. Higher scores suggest elevated psychopathology, hence, a worse outcome.

    Time frame: Baseline, post, and follow-up (8 month total)

  2. Change from baseline in intervention outcome

    Change in the Outcome Questionnaire (OQ) from baseline, measured 2 months and 6 months post-intervention. The OQ is a 45-item scale evaluating the quality of mental health care and its outcome featuring three sub-scales: subjective discomfort, interpersonal relations, and social role performance. The OQ scores range from 0 to 180. Higher scores indicate a worse outcome.

    Time frame: Baseline, post, and follow-up (8 month total)

Other outcomes

  1. Change from baseline mindful attention awareness

    Change in the Mindful Attention Awareness Scale (MAAS) from baseline, measured 2 months and 6 months post-intervention. The MAAS assesses awareness and mindful attention and is a common measure in psychological studies of mindfulness training. It gauges the extent to which participants acquired the target mindfulness skill. This is a 15-item, 6-point Likert scale with scores ranging from 15 to 90. Higher scores suggest a higher level of acquired the target mindfulness skills, hence, a better outcome.

    Time frame: Baseline, post, and follow-up (8 month total)

  2. The Feedback Questionnaire

    The Feedback Questionnaire (FBQ) measures the participants' satisfaction with the program and its contents. The FBQ was administered twice: as an immediate post-intervention assessment and, at a 6-month follow-up. The FBQ contains 21 items: 17 of which were ranked on a 5-point Likert scale, and 4 items were optional open questions. This outcome ranked from 1 to 5. Higher scores present more positive feedback to the treatment program, hence, a better outcome.

    Time frame: Post-intervention, and follow-up (6 month total)

  3. The Childhood Trauma Questionnaire

    The Childhood Trauma Questionnaire (CTQ) is a 28-item scale rated on a 5-point Likert scale. The CTQ has five subscales containing five items each: emotional abuse, physical abuse, sexual abuse, emotional neglect, and physical neglect. Each subscale is rated between 5 to 25. The total CTQ scale scores range from 25 to 125. Higher scores represent more childhood trauma, hence, a worse outcome.

    Time frame: Baseline (1 day)

07

Study locations

1 site
  • University of Haifa
    Haifa, 3498838, Israel
08

References and documents

Individual participant data

Plan to share: No — Non

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 11, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05235243
Lead sponsor
University of Haifa
Responsible party
Eli Somer (Professor Eli Somer, University of Haifa) — Principal investigator
First posted
Feb 11, 2022
Start date
Dec 20, 2018
Primary completion
Feb 3, 2020
Completion
Feb 28, 2021
Last update
Feb 11, 2022

Study contacts

Oren Herscu, PhD
study chair · School of Social Work, University of Haifa, Israel
Eli Somer, PhD
study director · School of Social Work, University of Haifa, Israel
Nirit Soffer-Dudek, PhD
principal investigator · Department of Psychology, Ben-Gurion University of the Negev, Israel

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion